Cargando…
Case Study of Two Post Vaccination SARS-CoV-2 Infections with P1 Variants in CoronaVac Vaccinees in Brazil
The rapid development of efficacious and safe vaccines against coronavirus disease 2019 (COVID-19) has been instrumental in mitigating the transmission of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Moreover, the emergence of SARS-CoV-2 variants raised concerns on the efficacy of t...
Autores principales: | Estofolete, Cassia F., Banho, Cecilia A., Campos, Guilherme R. F., Marques, Beatriz de C., Sacchetto, Livia, Ullmann, Leila S., Possebon, Fabio S., Machado, Luana F., Syrio, Juliana D., Araújo Junior, João P., Bittar, Cintia, Rahal, Paula, Lobo, Suzana M. A., Ferreira, Helena Lage, Vasilakis, Nikos, Nogueira, Mauricio L. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8309964/ https://www.ncbi.nlm.nih.gov/pubmed/34206727 http://dx.doi.org/10.3390/v13071237 |
Ejemplares similares
-
Heterologous Booster with BNT162b2 Induced High Specific Antibody Levels in CoronaVac Vaccinees
por: Masson, Letícia Carrijo, et al.
Publicado: (2023) -
Boosting immunity after CoronaVac
por: Sester, Martina, et al.
Publicado: (2022) -
Immunogenicity of Mix-and-Match CoronaVac/BNT162b2 Regimen versus Homologous CoronaVac/CoronaVac Vaccination: A Single-Blinded, Randomized, Parallel Group Superiority Trial
por: Samoud, Samar, et al.
Publicado: (2023) -
CoronaVac efficacy data from Turkey
por: McMenamin, Martina E, et al.
Publicado: (2021) -
CoronaVac: more data for regulators and policy makers
por: Ramasamy, Maheshi N, et al.
Publicado: (2021)